NYSE · CNTA
Healthcare · Biotechnology
$40.50
Up+$0.00 (+0.00%)
Updated Aug 19, 2026, 10:38 AM
SID Score
6.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CNTA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning CNTA.
CNTA research
Company profile and research snapshot.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 20, 2026 | Wells Fargo | Equal-Weight | — |
| Apr 2, 2026 | Guggenheim | Neutral | — |
| Apr 1, 2026 | Leerink Partners | Market Perform | — |
| Mar 31, 2026 | Needham | Hold | — |
| Mar 31, 2026 | Wolfe Research | Peer Perform | — |
No generated briefing is available yet.
Benzinga · Jun 22, 2026
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, which entered into a
Finnhub · May 11, 2026
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Centessa Pharmaceuticals plc to Eli Lilly and...
Benzinga · Apr 20, 2026
Wells Fargo analyst Benjamin Burnett downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Overweight to Equal-Weight and raises the price target from $35 to $42.
Yahoo · Apr 13, 2026
Pre-Market Stock Futures: Futures are trading lower this morning after negotiations with Iran failed over the weekend, and President Trump indicated the U.S. will block the Strait of Hormuz. This comes as we get set to start the first-quarter earnings season this week, as the major money-center banks and brokerage firms begin to report results ... Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Best Buy, Bilibili, Constellation Brands, CoreWeave, Nike, Starbucks, T-Mobile, and M
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CNTA.
